Key Highlights

  • PATH shares are trading down 16.03% intraday to $15.30, plunging nearly 17% following fiscal second-quarter results.
  • Revenue of $410.3 million beat estimates of $397.8 million, and adjusted EPS matched estimates.
  • Guidance was raised only modestly, with fiscal 2027 Revenue guidance moved to $1.789 billion-$1.794 billion, falling short of the growth reacceleration bulls wanted.
  • Gross margins narrowed to 80% from 82%, and third-quarter net new ARR guidance implied a slight year-over-year decline.
  • The company simultaneously announced a CFO transition, with Hitesh Ramani replacing Ashim Gupta, alongside a new board appointment.

Investors Punish Modest Guidance Despite the Beat

UiPath Inc. (NYSE:PATH) shares are plunging intraday as investors punish the stock following fiscal second-quarter results that beat on revenue and matched adjusted earnings-per-share estimates, but failed to show the growth reacceleration that bulls had wanted. Revenue of $410.3 million beat the $397.8 million estimate, while guidance was raised only modestly.

UiPath is a New York-based enterprise software company that provides an end-to-end automation platform centered on robotic process automation, AI agents, orchestration, process mining, document understanding, testing, and governance, serving large enterprises across financial services, healthcare, manufacturing, retail, and the public sector.

Margin Compression and Soft ARR Guidance Weigh on Shares

Gross margins narrowed to 80% from 82%, and third-quarter net new annual Recurring Revenue guidance implied a slight year-over-year decline, prompting a wave of analyst price target changes even as most maintained constructive ratings on the stock, with at least one firm issuing a notable downgrade citing valuation risk after the stock's sharp prior run-up.

Same-Day Leadership Transition Adds to Investor Caution

Adding to investor caution, the company simultaneously announced a CFO transition, with Hitesh Ramani replacing Ashim Gupta, alongside a new board appointment, with attention now shifting to the company's September 22 Investor Day for clearer evidence of accelerating growth.

Short Interest Climbs Ahead of Investor Day

UiPath carries a market Capitalization of roughly $8.14 billion following the decline. Short interest has climbed to nearly 22%-26% of float, reflecting heightened skepticism among some investors about the company's near-term growth trajectory ahead of the upcoming investor event.

Investor Day Becomes Key Test for Growth Narrative

With short interest elevated and investors seeking clearer evidence of accelerating growth, the company's September 22 Investor Day is shaping up as a key test for whether management can reset expectations and address the guidance concerns that drove today's decline.